PURR NASDAQ
Hyperliquid Strategies Inc Common Stock
1W: +1.1%
1M: -29.4%
3M: +47.2%
YTD: +163.7%
$9.85
+0.78 (+8.60%)
After Hours: $9.80 (-0.04, -0.46%)
Weekly Expected Move ±10.5%
$7
$8
$9
$10
$11
Credit Risk of going bust: not rated, financial company (lending is its business) Bonds: none of note held by US funds details ▾
Not rated: lending and leverage are a financial company's business, which the model misreads.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
6 relationships6
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2025-12-03
Earliest Filing
2025-12-03
Latest Filing
partner: 5
acquirer: 1
Counterparties (Filed by PURR)
6 relationshipsCompanies named in PURR's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Hyperliquid Strategies Inc | PURR | acquirer | Parent company entering advisor rights agreement | 2025-12-03 | View |
| Rorschach Advisors LLC | — | partner | Advisor entering rights agreement | 2025-12-03 | View |
| Rorschach I LLC | — | partner | Entity party to Business Combination Agreement | 2025-12-03 | View |
| Sonnet BioTherapeutics Holdings, Inc. | — | partner | Entity party to Business Combination Agreement | 2025-12-03 | View |
| Rorschach Merger Sub LLC | — | partner | Merger subsidiary party to Business Combination Agreement | 2025-12-03 | View |
| TBS Merger Sub Inc | — | partner | Merger subsidiary party to Business Combination Agreement | 2025-12-03 | View |
Recent 8-K Filings (11)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-26 | Regulation FD; Exhibits | View | |
| 2026-09-15 | Material Agreement; Exhibits | Agreement | View |
| 2026-09-14 | Material Agreement; Exhibits | Agreement | View |
| 2026-09-01 | Material Agreement; Exhibits | Agreement | View |
| 2026-08-27 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-06-26 | Officer/Director Change; Exhibits | View | |
| 2026-05-07 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-02-18 | Financial Statements and Exhibits | View | |
| 2026-02-11 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-12-08 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-12-03 | Entry into Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Unregi | Agreement Acquisition | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR